SEC Form 4 · accession 0001144204-18-016189

Dicerna Pharmaceuticals Inc · DRNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Peter Kolchinsky

Director

Period of report

Mar 19, 2018

Accepted (ET)

Mar 21, 2018 · 4:53 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001399529

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2,F3	Mar 19, 2018	D	84,670	$12.6308	D	4,377,643	I	See Note
Common Stock^F1,F2,F3	Mar 19, 2018	D	34,700	$12.455	D	4,342,943	I	See Note
Common Stock^F1,F2,F3	Mar 20, 2018	D	50,000	$11.00	D	4,292,943	I	See Note
Common Stock^F1,F2,F3	Mar 20, 2018	D	55,200	$11.1555	D	4,237,743	I	See Note
Common Stock^F1,F2,F3	Mar 20, 2018	D	67,985	$11.1648	D	4,169,758	I	See Note
Common Stock^F1,F2,F3	Mar 21, 2018	D	64,600	$11.2399	D	4,105,158	I	See Note
Common Stock^F1,F2,F3	Mar 21, 2018	D	31,145	$11.0718	D	4,074,013	I	See Note
Common Stock^F1,F2,F3	Mar 21, 2018	D	49,000	$11.14	D	4,025,013	I	See Note
Common Stock^F1,F2,F3	Mar 21, 2018	D	36,224	$11.1727	D	3,988,789	I	See Note

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1Peter Kolchinsky is a director of the Issuer and the sole manager of RA Capital Management, LLC (the "Adviser") which is the general partner of RA Capital Healthcare Fund, L.P. (the "Fund"). The Fund is a shareholder of the Issuer.
F2406,542 of the aggregate common stock beneficially sold in the transactions were held directly by the Fund. The Adviser and Mr. Kolchinsky may be deemed indirect beneficial owners of such securities. The Adviser and Mr. Kolchinsky disclaim beneficial ownership of the reported securities in reliance on Rule 16a-1(a)(1)(v) and (vii) under the Securities Exchange Act of 1934, as amended (the "Act") and disclaim any obligation to file reports under Section 16 other than, in the case of Mr. Kolchinsky, as a director. Pursuant to Rule 16a-1, Mr. Kolchinsky disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. The filing of this Form 4 shall not be construed as an admission that Mr. Kolchinsky or the Adviser is or was for the purposes of Section 16(a) of the Act, or otherwise, the beneficial owner of any of securities reported herein.
F366,982 of the common stock beneficially sold in the transactions were held in a separately managed account for which the Advisor serves as investment adviser (the "Account"). Mr. Kolchinsky, the Adviser and the Fund have no pecuniary interest in the reported securities sold by the Account and disclaim: (A) beneficial ownership of securities held in the Account for purposes of Rule 16a-1(a)(2) and (B) beneficial ownership of securities held by the Fund, for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.